Can vistry finally put its ‘annus horribilus’ behind it?

The market has ‘digested’ the stamp-duty rush and demand looks healthy

Companies in the news ...and how they were assessed

Media group burned bright but faded as it encountered structural and cyclical challenges

Stocks are living their best life while the dollar is having its worst year since 1973

Two combinations in broader Europe sector and a take-private bid for renewables vehicle among the sector’s latest deals

Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say